Mark Savill, PhD

TitlePostdoctoral Scholar
InstitutionUniversity of California San Francisco
Address401 Parnassus Ave.
San Francisco CA 94143
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Savill M, Sardo A, Patel P, Loewy R, Melnikow J, Niendam T. Which components of specialized early intervention for psychosis do senior providers see as most important? Early Interv Psychiatry. 2018 Jun 08. PMID: 29882258.
      View in: PubMed
    2. Karcher NR, Barch DM, Avenevoli S, Savill M, Huber RS, Simon TJ, Leckliter IN, Sher KJ, Loewy RL. Assessment of the Prodromal Questionnaire-Brief Child Version for Measurement of Self-reported Psychoticlike Experiences in Childhood. JAMA Psychiatry. 2018 Jun 06. PMID: 29874361.
      View in: PubMed
    3. Savill M, Skymba HV, Ragland JD, Niendam T, Loewy RL, Lesh TA, Carter C, Goldman HH. Acceptability of Psychosis Screening and Factors Affecting Its Implementation: Interviews With Community Health Care Providers. Psychiatr Serv. 2018 Apr 02; appips201700392. PMID: 29606073.
      View in: PubMed
    4. Savill M, D'Ambrosio J, Cannon TD, Loewy RL. Psychosis risk screening in different populations using the Prodromal Questionnaire: A systematic review. Early Interv Psychiatry. 2018 Feb; 12(1):3-14. PMID: 28782283.
      View in: PubMed
    5. Farreny A, Savill M, Priebe S. Correspondence between negative symptoms and potential sources of secondary negative symptoms over time. Eur Arch Psychiatry Clin Neurosci. 2017 Jun 02. PMID: 28577223.
      View in: PubMed
    6. Savill M, Orfanos S, Bentall R, Reininghaus U, Wykes T, Priebe S. The impact of gender on treatment effectiveness of body psychotherapy for negative symptoms of schizophrenia: A secondary analysis of the NESS trial data. Psychiatry Res. 2017 01; 247:73-78. PMID: 27871030.
      View in: PubMed
    7. Priebe S, Savill M, Wykes T, Bentall R, Lauber C, Reininghaus U, McCrone P, Mosweu I, Bremner S, Eldridge S, Röhricht F. Clinical effectiveness and cost-effectiveness of body psychotherapy in the treatment of negative symptoms of schizophrenia: a multicentre randomised controlled trial. Health Technol Assess. 2016 Feb; 20(11):vii-xxiii, 1-100. PMID: 26869182; PMCID: PMC4782808.
    8. Savill M, Priebe S. Letter to the Editor: Concepts and methods when considering negative symptom course: a reply. Psychol Med. 2015 Aug; 45(11):2459-60. PMID: 25919939.
      View in: PubMed
    9. Savill M, Banks C, Khanom H, Priebe S. Do negative symptoms of schizophrenia change over time? A meta-analysis of longitudinal data. Psychol Med. 2015 Jun; 45(8):1613-27. PMID: 25425086.
      View in: PubMed
    10. Barnicot K, Savill M, Bhatti N, Priebe S. A pragmatic randomised controlled trial of dialectical behaviour therapy: effects on hospitalisation and post-treatment follow-up. Psychother Psychosom. 2014; 83(3):192-3. PMID: 24752222.
      View in: PubMed
    11. Priebe S, Savill M, Reininghaus U, Wykes T, Bentall R, Lauber C, McCrone P, Röhricht F, Eldridge S. Effectiveness and cost-effectiveness of body psychotherapy in the treatment of negative symptoms of schizophrenia--a multi-centre randomised controlled trial. BMC Psychiatry. 2013 Jan 14; 13:26. PMID: 23317474; PMCID: PMC3556155.
    12. Katsakou C, Marougka S, Barnicot K, Savill M, White H, Lockwood K, Priebe S. Recovery in Borderline Personality Disorder (BPD): a qualitative study of service users' perspectives. PLoS One. 2012; 7(5):e36517. PMID: 22615776; PMCID: PMC3355153.
    13. Savill M, Jankovic J, Katsakou C, Kallert T, Priebe S. Symptom levels and initial appraisal of hospital treatment in patients with schizophrenia. Psychiatry Res. 2012 Sep 30; 199(2):79-83. PMID: 22565214.
      View in: PubMed
    14. Barnicot K, Katsakou C, Bhatti N, Savill M, Fearns N, Priebe S. Factors predicting the outcome of psychotherapy for borderline personality disorder: a systematic review. Clin Psychol Rev. 2012 Jul; 32(5):400-12. PMID: 22681913.
      View in: PubMed